| Polymicrobial interactions: impact on pathogenesis and human disease BM Peters, MA Jabra-Rizk, GA O'May, JW Costerton, ME Shirtliff Clinical microbiology reviews 25 (1), 193-213, 2012 | 853 | 2012 |
| Antimicrobial peptides: primeval molecules or future drugs? BM Peters, ME Shirtliff, MA Jabra-Rizk PLoS pathogens 6 (10), e1001067, 2010 | 586 | 2010 |
| Pathogenesis of Candida albicans biofilm C Tsui, EF Kong, MA Jabra-Rizk FEMS Pathogens and Disease 74 (4), ftw018, 2016 | 526 | 2016 |
| Oral candidiasis: A disease of opportunity T Vila, AS Sultan, D Montelongo-Jauregui, MA Jabra-Rizk Journal of fungi 6 (1), 15, 2020 | 522 | 2020 |
| Cross-kingdom interactions: Candida albicans and bacteria ME Shirtliff, BM Peters, MA Jabra-Rizk FEMS microbiology letters 299 (1), 1-8, 2009 | 508 | 2009 |
| Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility MA Jabra-Rizk, TF Meiller, CE James, ME Shirtliff Antimicrobial agents and chemotherapy 50 (4), 1463-1469, 2006 | 451 | 2006 |
| Streptococcus mutans, Candida albicans, and the Human Mouth: A Sticky Situation KH Metwalli, SA Khan, BP Krom, MA Jabra-Rizk PLoS pathogens 9 (10), e1003616, 2013 | 443 | 2013 |
| Fungal biofilms and drug resistance MA Jabra-Rizk, WA Falkler, TF Meiller Emerging infectious diseases 10 (1), 14, 2004 | 417 | 2004 |
| Microbial interactions and differential protein expression in Staphylococcus aureus–Candida albicans dual-species biofilms BM Peters, MA Jabra-Rizk, MA Scheper, JG Leid, JW Costerton, ... FEMS Immunology & Medical Microbiology 59 (3), 493-503, 2010 | 339 | 2010 |
| Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue LM Schlecht, BM Peters, BP Krom, JA Freiberg, GM Hänsch, SG Filler, ... Microbiology 161 (1), 168-181, 2015 | 306 | 2015 |
| Farnesol-Induced Apoptosis in Candida albicans ME Shirtliff, BP Krom, RAM Meijering, BM Peters, J Zhu, MA Scheper, ... Antimicrobial agents and chemotherapy 53 (6), 2392-2401, 2009 | 296 | 2009 |
| Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix EF Kong, C Tsui, S Kucharíková, D Andes, P Van Dijck, MA Jabra-Rizk MBio 7 (5), 10.1128/mbio. 01365-16, 2016 | 276 | 2016 |
| Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p BM Peters, ES Ovchinnikova, BP Krom, LM Schlecht, H Zhou, LL Hoyer, ... Microbiology 158 (12), 2975-2986, 2012 | 257 | 2012 |
| Candida albicans pathogenesis: fitting within the host-microbe damage response framework MA Jabra-Rizk, EF Kong, C Tsui, MH Nguyen, CJ Clancy, PL Fidel Jr, ... Infection and immunity 84 (10), 2724-2739, 2016 | 247 | 2016 |
| Peptide Nucleic Acid Fluorescence In Situ Hybridization-Based Identification of Candida albicans and Its Impact on Mortality and Antifungal Therapy Costs GN Forrest, K Mankes, MA Jabra-Rizk, E Weekes, JK Johnson, ... Journal of clinical microbiology 44 (9), 3381-3383, 2006 | 213 | 2006 |
| A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide TF Meiller, B Hube, L Schild, ME Shirtliff, MA Scheper, R Winkler, A Ton, ... PloS one 4 (4), e5039, 2009 | 180 | 2009 |
| The power of saliva: Antimicrobial and beyond T Vila, AM Rizk, AS Sultan, MA Jabra-Rizk PLoS pathogens 15 (11), e1008058, 2019 | 160 | 2019 |
| Identification of Candida dubliniensisin a Prospective Study of Patients in the United States MA Jabra-Rizk, A Baqui, JI Kelley, WA Falkler Jr, WG Merz, TF Meiller Journal of clinical microbiology 37 (2), 321-326, 1999 | 159 | 1999 |
| Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us EF Kong, JK Johnson, MA Jabra-Rizk PLoS pathogens 12 (10), e1005837, 2016 | 152 | 2016 |
| “Persisters”: survival at the cellular level CC Dawson, C Intapa, MA Jabra-Rizk PLoS pathogens 7 (7), e1002121, 2011 | 143 | 2011 |
